Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Otoole David D
Relationship:   Chief Financial Officer
City:   Los Angeles
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   158,937    

Indirect Shares

   0      
Direct Value   $301,605    

Indirect Value

   $0      
Total Shares   158,937      
Total Value   $301,605      


Response Genetics Inc $0 Codexis Inc $294,427 Soleno Therapeutics Inc $7,178 Response Genetics Inc $0 Codexis Inc $294,427 Soleno Therapeutics Inc $7,178
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    5    

     Stock price went up :
    3   
    4    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   3.0   
   4.0   
     Percentage Gain/Loss :
   18.5%
 21.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Response Genetics Inc RGDX Officer 2010-05-03 3,500 0    Premium*  
            Codexis Inc CDXS SVP & Chief Financial ... 2013-09-04 110,687 2012-09-10 0    Premium*  
            Soleno Therapeutics Inc SLNO See Remarks 2016-08-18 44,750 2015-03-13 0    Premium*  
            Opiant Pharmaceuticals Inc OPNT Chief Financial Officer 2023-03-02 0 2018-05-11 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2023-03-02 4 D $20.00 $724,960 D/D (36,248) 0 0 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2023-01-27 4 S $20.26 $10,961 D/D (541) 34,248 0 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2023-01-09 4 S $20.20 $8,383 D/D (415) 34,789 0 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2023-01-05 4 S $20.20 $32,320 D/D (1,600) 35,204 0 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2022-07-14 4 S $11.10 $8,647 D/D (779) 36,804 0 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2022-06-27 4 A $0.00 $0 D/D 2,000 37,583 0 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2022-01-10 4 S $30.60 $13,219 D/D (432) 35,583 0 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2022-01-04 4 A $0.00 $0 D/D 12,000 36,015 0 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2021-09-14 4 B $19.05 $3,824 D/D 200 24,015 2.66 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2021-08-16 4 B $15.38 $9,228 D/D 600 23,815 2.74 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2021-01-26 4 A $0.00 $0 D/D 7,850 23,215 0 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2020-06-11 4 B $8.74 $8,740 D/D 1,000 15,365 2.74 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2020-05-26 4 B $11.00 $11,000 D/D 1,000 14,365 2.74 %
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2020-01-07 4 A $0.00 $0 D/D 4,150 13,365 0 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2019-11-26 4 B $13.22 $1,322 D/D 100 9,215 2.66 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2019-08-15 4 B $15.20 $15,200 D/D 1,000 8,015 2.74 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2019-08-13 4 B $15.46 $15,460 D/D 1,000 7,015 2.74 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2018-08-14 4 B $15.39 $15,636 D/D 1,015 6,015 2.74 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2018-05-16 4 B $16.95 $33,900 D/D 2,000 5,000 2.74 -
OPNT Opiant Pharmaceuticals In... Chief Financial Officer   •       –      –    2018-05-11 4 B $18.85 $56,550 D/D 3,000 3,000 2.74 -
SLNO Soleno Therapeutics Inc See Remarks   •       –      –    2016-08-18 4 B $1.01 $2,020 D/D 2,000 44,750 2.66 -
SLNO Soleno Therapeutics Inc See Remarks   •       –      –    2016-08-17 4 B $0.92 $9,238 D/D 10,000 42,750 2.74 -
SLNO Soleno Therapeutics Inc See Remarks   •       –      –    2016-05-12 4 B $1.16 $5,775 D/D 5,000 32,750 2.74 -
SLNO Soleno Therapeutics Inc SVP & Chief Financial Officer   •       –      –    2015-11-17 4 B $1.79 $8,950 D/D 5,000 27,750 2.74 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us